Trial intelligence / Profile preview

Real-world neoadjuvant pyrotinib study in HER2-positive breast cancer

ChiCTR1900026061Phase 4Not yet recruiting

Sponsor

The First Affiliated Hospital of Guangxi Medical University

Start

Oct 2019

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1